Nat. Rev. Endocrinol. doi: /nrendo

Slides:

Advertisements

Similar presentations

Diagnosis of Type 2 Diabetes 1. Diagnostic Criteria for Prediabetes and Diabetes in Nonpregnant Adults 2 NormalHigh Risk for DiabetesDiabetes FPG

Advertisements

1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.

Prediabetes Burden.

Non-diabetes 64.7% Diabetes 35.3% Diagnosed diabetes 5.6% Pre-diabetes 26.0% Undiagnosed diabetes 2.8% Age-adjusted diabetes prevalence among Alaska adults,

Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.

Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(

Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.

Small Steps to Big Rewards Diabetes Prevention Program Slyter Nutrition Consulting Services

Diagnosis Glucose tolerance is classified into three broad categories: normal glucose homeostasis, diabetes mellitus, and impaired glucose homeostasis.

Epidemiology of Diabetes in Hispanic Americans. Prevalence of Abnormal Glucose Tolerance in Three Ethnic Groups.

Measures of Hyperglycemia Random plasma glucose (RPG)—without regard to time of last meal Fasting plasma glucose (FPG)—before breakfast Oral glucose tolerance.

Screening for Diabetes in Pregnancy

بايو كمستري (م 3) / د . احمد الطويل

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 3 Life expectancy at birth in all countries included

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Pathophysiology of hyperglycaemia in T2DM

with undiagnosed diabetes mellitus by three diagnostic criteria

Figure 4 Amino acid structure of short-acting and long-acting insulins

Screening for Diabetes in Pregnancy

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Mendelian randomization study

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Monogenic forms of diabetes mellitus

Nat. Rev. Cardiol. doi: /nrcardio

The prevalence of diabetes (A), impaired glucose tolerance (B), impaired fasting glucose (C), and impaired glucose metabolism (D) among those with Finnish.

Nat. Rev. Endocrinol. doi: /nrendo

Physical activity and prevention of type 2 diabetes

Nat. Rev. Endocrinol. doi: /nrendo

Prediabetes Burden.

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 4 Effects of irisin on glucose homeostasis

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Osteosarcoma epidemiology

Figure 1 Challenges and opportunities of using omics in EDC research

Figure 1 Oestrogen biosynthesis and production sites in the body

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Pharmacokinetic action profiles of rapid-acting insulins

Figure 4 Tracheal endoscopy in two patients

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.

Figure 3 Clinical algorithms in the management of NASH and diabetes mellitus Figure 3 | Clinical algorithms in the management of NASH and diabetes mellitus.

Nat. Rev. Endocrinol. doi: /nrendo

کنفرانس دیابت ارایه دهنده : هادی عبداله زاد، دکترای تغذیه

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.

Nat. Rev. Endocrinol. doi: /nrendo

Figure 3 Pharmacodynamic action profiles of long-acting insulins

Nat. Rev. Endocrinol. doi: /nrendo

David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD The Lancet

Figure 1 Sites of action of glucose-lowering agents

Proportion of participants with type 2 diabetes (diabetes categories are defined according to the American Diabetes Association 2010 Diagnostic Guidelines),

Figure 2 Gut microbial gene content and development of T1DM

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Timeline of pancreatic islet transplantation

Figure 1 Exercise enhances insulin sensitivity

Age-adjusted and sex-adjusted prevalence of diabetes of Asian immigrants and whites in California from 2003 to Age-adjusted and sex-adjusted prevalence.

Figure 3 Global iodine status and mandatory salt iodization

Prevalence of diabetes (DM) after pancreaticoduodenectomy for PDAC

Impaired fasting glucose (IFG), impaired glucose tolerance (IGT), diabetes, prehypertension and hypertension prevalence by wealth quintile, age group and.

Nat. Rev. Endocrinol. doi: /nrendo

Schematic depiction of three stages of the natural history of T2D, noting several opportunities for improvement of management. Schematic depiction of three.

The age-specific prevalence using simple linear regression analysis for the known type 1 and type 2 diabetic patients (A) and the newly diagnosed diabetic.

Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.105 Figure 3 The percentage of US adults aged >18 years (NHANES 2005–2008) with a | intermediate hyperglycaemia (WHO) or b | prediabetes (ADA, 2003 criteria) Figure 3 | The percentage of US adults aged >18 years (NHANES 2005–2008) with a | intermediate hyperglycaemia (WHO) or b | prediabetes (ADA, 2003 criteria)27. IFG, impaired fasting glycaemia; IGT, impaired glucose tolerance. Zimmet, P. et al. (2016) Diabetes mellitus statistics on prevalence and mortality: facts and fallacies Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.105